Lumos Pharma(LUMO) - 2022 Q1 - Earnings Call Presentation

P H A R M 1 First Quarter 2022 Financial Results & Clinical Update May 10, 2022 Forward Looking Statements This presentation contains forward-looking statements of Lumos Pharma, Inc. that involve substantial risks and uncertainties. All such statements contained in this presentation are forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, a law that gives us the opportunity to share our outlook for the future without fear of litigation if it turns out our pr ...